Search

everythinglearnresearchcommunity

for

Search:↓

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

PSA can help diagnose high androgen levels in women.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Finasteride improves prostate cancer detection in PSA test.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Some common medications can lower PSA levels in 45-year-old German men.

Shorter PSADT after prostate surgery is linked to higher risk of death.

CT scans can find serious prostate cancer even when PSA levels are low.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

IsoPSA test works accurately even if patients take certain prostate medications.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Baseline PSA levels affect general health and sexual satisfaction in men with BPH treated with finasteride or placebo.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

The uric acid to creatinine ratio is a strong indicator for diagnosing PCOS.